The Law Offices of Rosenberg, Kirby, Cahill & Stankowitz
Practice Areas

August 29, 2000-Judge Oks on Diet Drug Linked to Heart Valve Damage

A federal judge has approved a proposed $ 3.75 billion national settlement of health claims stemming from the diet drug combination fen-phen, which has been linked to potentially fatal heart valve damage.

Under the settlement approved Monday, fen-phen users would get up to $ 1.5 million, though most would get far less, depending on their level of injury and how long they took the drugs. The settlement also includes money for future medical monitoring. U.S. District Judge Louis C. Bechtle gave preliminary approval to the settlement in November. Barring an appeal, attorneys said Fen-Phen users could begin receiving settlement checks as early as January. More than 9,000 lawsuits have been filed against American Home Products, maker of fenfluramine, the "fen" in the Fen-Phen diet drug combination. The Madison, N.J.-based company sold the combination under the brand name of Pondimin and also made Redux, a chemical cousin.

The drugs were withdrawn in September 1997 after a Mayo Clinic study linked Fen-Phen to potentially fatal heart valve damage. The second drug in the combination, phentermine, was not linked to the problems. "The settlement resolves the vast majority of the claims and potential claims that the company was facing, and it's a very, very significant step forward in resolving the litigation," said Michael Scott of Philadelphia, one of the attorneys representing American Home.

Plaintiff attorneys have objected to the settlement in June on behalf of a group of diet-drug users, saying it would likely be reversed because of all the other lawsuits pending. Blizzard did not immediately return a call for comment Monday. Attorneys have said they would appeal if the settlement was approved.

Other opponents have complained that the monetary damages don't go far enough, that the settlement doesn't include compensation for people who may develop health problems later, and that users had inadequate representation. Of 6 million people who took Fen-Phen before it was pulled from the market, about 45,000 have refused the settlement and retain the right to sue for punitive damages. Some 266,000 others have registered to join the class and may still reject the settlement and sue for compensatory damages but not punitive damages.

If you or a loved one has suffered an injury as a result of taking any drug or supplement, call The Law Offices of Rosenberg, Kirby, Cahill & Stankowitz now at (732) 341-3337 or CLICK HERE TO SUBMIT A SIMPLE CASE FORM. The initial consultation is free of charge, and if we agree to review your case, we will work on a contingent fee basis, which means we get paid for our services only if there is a monetary award or recovery of funds. Don't delay! You may have a valid claim and be entitled to compensation for your injuries, but a lawsuit must be filed before the statute of limitations expires.

<< back


The above is not legal advice. That can only come from a qualified attorney who is familiar with all the facts and circumstances of a particular, specific case and the relevant law. See Terms of Use.

Contact Us
For questions about personal injury laws, fill out the form below or contact us by phone.
Law Offices of
Rosenberg, Kirby,
Cahill & Stankowitz

29 Main Street
Toms River, NJ 08753

(732) 341-3337
Toms River/Central Ocean

(609) 971-7300
Southern Ocean

(732) 785-9145
Northern Ocean/Monmouth
Today's Legal Headlines
Video Library
Legal Dictionary
Statute of Limitations
New Jersey Resources
Home  |  About Us  |  Attorney Profile  |  Contact Us  |  Verdicts & Settlements  |  Newsletter

Copyright© 2009 The Law Offices of Rosenberg Kirby Cahill & Stankowitz All rights reserved
Developed by LawyerEdge